Journal of Diabetes & Metabolism

ISSN - 2155-6156

+441518081309

PREVALENCE AND RISK FACTORS OF GASTROPARESIS-RELATED SYMPTOMS AMONG PATIENTS WITH TYPE 2 DIABETES

18th European Diabetes Congress

July 17-18, 2017|Lisbon, Portugal

Metab Algeffari, Rakan Almogbel, Fulwa Alhussan and Suliman Alnasser

Qassim University College of Medicine, Saudi Arabia

Posters & Accepted Abstracts: J Diabetes Metab

Abstract :

Background: The prevalence of gastroparesis in type 2 diabetes mellitus (T2DM) varies widely. Our aim is to estimate the prevalence of clinical symptoms of gastroparesis among patients with type 2 diabetes mellitus and explore the relationship between gastroparesis and other risk factors. Methods: A cross-sectional study evaluating 147 type 2 diabetics using the gastroparesis cardinal symptoms index (GCSI). A GCSI total score ?1.90 were chosen as having definite symptoms of gastroparesis. All patients completed a demographic questionnaire and interviewed to complete the demographic data. Disease duration, medication, comorbidities, recent blood glucose and HbA1C were collected and investigated. Results: The prevalence of clinical symptoms of gastroparesis among type 2 diabetics was 10.8%. Clinical symptoms of gastroparesis were significantly correlated to HbA1c (p=0.001), blood glucose (p=0.003), duration of diabetes (p=0.02) and comorbidities (p=0.009). The most common symptoms were bloating, stomach fullness and early satiety (63.94%, 55.1% and 48.3% respectively). In logistic regression analysis, female gender emerged as significant independent predictors of the presence of at least one symptom. Conclusions: The prevalence of clinical symptoms of gastroparesis observed in the Saudi patients diagnosed with type 2 diabetes was 10.8% and is independently associated with poor controlled diabetes, hyperglycemia, and long duration of diabetes and history of co-morbid conditions.

Top